News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Daniel Heng: EV Prembrolizumab for metastatic bladder cancer
Daniel Heng/X
Jun 2, 2025, 08:58

Daniel Heng: EV Prembrolizumab for metastatic bladder cancer

Daniel Heng, Head of Medical Oncology at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary, Alberta, shared on X:

“EV Prembrolizumab for metastatic bladder cancer: CR rates are high and their duration of response long. Definitely the standard of care. CR patients had an average of 13 cycles of EV. Optimizing and learning about EV dosing and weaning in CR patients is important.”

Daniel Heng: EV Prembrolizumab for metastatic bladder cancer

ASCO 2025 bladder cancer cancer Daniel Heng OncoDaily Oncology
Special Coverage
Insight
Jul 2, 2025, 05:44
Uniting for Impact: Rethinking Cancer Policy and Research Through the EU Cancer Mission at the 2nd Synergies Forum on Cancer
Oncolibrary
Jul 2, 2025, 01:28
Comprehensive Chemotherapy Safety Guidelines: Protecting Patients, Staff, and Caregivers
Science
Jul 2, 2025, 01:06
FDA Oncology News: June 2025 Updates
Blog
Jul 1, 2025, 19:04
Jasmine Kamboj: Journey of Empowering Oncologists - 1st Ten Episodes
Blog
Jul 1, 2025, 18:46
AACR Thanks CBS and Ted Koppel for Spotlighting NIH Budget Threats to Cancer Research
Blog
Jul 1, 2025, 18:33
Partha Basu Shares IARC Study Linking Vaginal Microbiome to Cervical Precancer Treatment Outcomes
Blog
Jul 1, 2025, 18:22
EORTC Hiring Junior Clinical Operations Managers to Join Brussels HQ
Career
Jul 1, 2025, 18:11
Andreas Charalambous: I am Honoured to Have Been Appointed Chair of the Scientific Advisory Board of SPCC
Career
Jul 1, 2025, 18:00
Kenji López-Cuevas: Joining the Scientific Advisory Board of SPCC for the 2025-2028 Term
Blog
Jul 1, 2025, 17:59
Haimanot Kasahun: It's a Privilege to Serve as BOAA's Planning Committee
Science
Jul 1, 2025, 17:49
Aakash Desai: Clinical Outcomes of Perioperative Immunotherapy in Resectable NSCLC
Blog
Jul 1, 2025, 17:38
The First Day of the 2nd Synergies Forum on Cancer of the Hellenic Cancer Federation